Science Explorer Interactive view Map

AcelRx Pharmaceuticals (United States)

Research works
24
▼ 73% vs 2013–17
Citations
236
9.7 per fractional work
Top-10% rate
15.3%
record average 16.5%
Open access
36%
world 28%

Not ranked overall: AcelRx Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at AcelRx Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Pain Management, Postoperative Pain, Chronic Pain, Pain Assessment Tools, Elderly Patients, Analgesia, Regional Anesthesia and Surgical Outcome.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 21 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Pain Management10▲ 177×4 topics
  2. Postoperative Pain8▲ 333×3 topics
  3. Chronic Pain7▲ 118×4 topics
  4. Pain Assessment Tools6▲ 446×2 topics
  5. Elderly Patients4▲ 140×2 topics
  6. Analgesia4▲ 236×2 topics
  7. Regional Anesthesia4▲ 296×1 topic
  8. Surgical Outcome4▲ 296×1 topic
  9. Cancer Pain4▲ 598×1 topic
  10. Opioid Analgesics4▲ 598×1 topic
  11. Pharmacokinetics3▲ 42×4 topics
  12. Sedation3▲ 128×2 topics
  13. Inflammation2▲ 4.2×7 topics
  14. Anesthesia2▲ 77×2 topics
  15. Bispectral Index Monitoring2▲ 193×1 topic
  16. Dexmedetomidine2▲ 193×1 topic
  17. Pain Measurement2▲ 294×1 topic
  18. Pediatric Pain2▲ 294×1 topic
  19. Cancer1▲ 3.6×4 topics
  20. Chronic Pain Management1▲ 197×1 topic
  21. Opioid Prescribing1▲ 197×1 topic

Which research topics does AcelRx Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Diet and metabolism studies, Hyperglycemia and glycemic control in critically ill and hospitalized patients, Cancer, Hypoxia, and Metabolism and Blood groups and transfusion.

  1. 1 Diet and metabolism studies Physiology 0 works
  2. 2 Hyperglycemia and glycemic control in critically ill and hospitalized patients Endocrinology, Diabetes and Metabolism 0 works
  3. 3 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  4. 4 Blood groups and transfusion Hematology 0 works
  5. 5 Neonatal Health and Biochemistry Pediatrics, Perinatology and Child Health 0 works
  6. 6 Hemoglobinopathies and Related Disorders Genetics 0 works
  7. 7 Trauma, Hemostasis, Coagulopathy, Resuscitation Critical Care and Intensive Care Medicine 0 works
  8. 8 Pain Mechanisms and Treatments Physiology 0 works
  9. 9 Acute Kidney Injury Research Nephrology 0 works
  10. 10 Heparin-Induced Thrombocytopenia and Thrombosis Surgery 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.6%not open64.4%

World: 28% of research is openly available.

with international co-authors22.2%domestic only77.8%

World: 19% is written across borders.

How has AcelRx Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 73% lower than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Redwood City

All research institutions in Redwood City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.